**Question:** Which of the following is a DNA repair defect?

A. Xeroderma Pigmentosum
B. Cockayne syndrome
C. Ataxia Telangiectasia
D. Nijmegen Breakage Syndrome

**Core Concept:** DNA repair is a crucial process that helps maintain the integrity of genetic material by correcting errors or damage that can occur during DNA replication, transcription, or exposure to environmental factors. DNA repair defects are conditions caused by mutations in genes involved in these processes.

**Why the Correct Answer is Right:**

C. Ataxia Telangiectasia (AT) is a DNA repair defect caused by mutations in the ATM gene that encodes the protein Ataxia Telangiectasia Mutated (ATM). ATM is a serine/threonine kinase that plays a role in the DNA damage response, including activation of checkpoints, apoptosis, and repair of DNA double-strand breaks. The absence or dysfunction of ATM impairs the ability to repair DNA damage, leading to genomic instability, increased cancer risk, and characteristic features such as progressive cerebellar ataxia, oculocutaneous telangiectasia, and immunodeficiency.

**Why Each Wrong Option is Incorrect:**

A. Xeroderma Pigmentosum (XP) is caused by mutations in the nucleotide excision repair pathway, which is responsible for removing damaged bases and bulky adducts from DNA. XP patients have increased sensitivity to sunlight and an increased risk of skin cancer, but they are not characterized by cerebellar ataxia, oculocutaneous telangiectasia, or immunodeficiency.

B. Cockayne syndrome is caused by mutations in genes involved in the transcription-coupled nucleotide excision repair pathway, which is responsible for repairing damage in the vicinity of actively transcribing RNA polymerase II. Patients with Cockayne syndrome present with developmental abnormalities, photosensitivity, and cerebellar atrophy. XP and Cockayne syndrome are distinct disorders with overlapping features, but they differ in the type of DNA damage they are unable to repair.

D. Nijmegen Breakage Syndrome (NBS) is characterized by mutations in genes involved in the non-homologous end joining (NHEJ) pathway, which repairs DNA double-strand breaks. NBS patients exhibit immunodeficiency, growth retardation, and an increased risk of malignancies, but they are not characterized by oculocutaneous telangiectasia or cerebellar ataxia. XP, Cockayne syndrome, and Nijmegen Breakage Syndrome are distinct disorders with overlapping features, but they differ in the type of DNA damage they are unable to repair and the clinical manifestations they present with.